Envestnet Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $111M | Buy |
1,825,394
+291,858
| +19% | +$17M | 0.03% | 498 |
|
|
2025
Q4 | $82.7M | Sell |
1,533,536
-211,603
| -12% | -$10.2M | 0.02% | 555 |
|
|
2025
Q3 | $78.7M | Sell |
1,745,139
-242,196
| -12% | -$11.3M | 0.02% | 583 |
|
|
2025
Q2 | $92M | Sell |
1,987,335
-1,246,252
| -39% | -$61.2M | 0.03% | 521 |
|
|
2025
Q1 | $197M | Sell |
3,233,587
-297,525
| -8% | -$17.3M | 0.06% | 292 |
|
|
2024
Q4 | $200M | Buy |
3,531,112
+618,047
| +21% | +$34.5M | 0.06% | 282 |
|
|
2024
Q3 | $151M | Buy |
2,913,065
+644,178
| +28% | +$30.2M | 0.05% | 369 |
|
|
2024
Q2 | $94.2M | Buy |
2,268,887
+34,643
| +2% | +$1.55M | 0.03% | 468 |
|
|
2024
Q1 | $121M | Buy |
2,234,244
+276,010
| +14% | +$14.1M | 0.05% | 395 |
|
|
2023
Q4 | $100M | Sell |
1,958,234
-502,099
| -20% | -$26.4M | 0.04% | 411 |
|
|
2023
Q3 | $143M | Sell |
2,460,333
-425,847
| -15% | -$26.1M | 0.07% | 287 |
|
|
2023
Q2 | $185M | Sell |
2,886,180
-4,327,820
| -60% | -$290M | 0.08% | 210 |
|
|
2023
Q1 | $186M | Buy |
7,214,000
+4,755,058
| +193% | +$335M | 0.09% | 201 |
|
|
2022
Q4 | $177M | Buy |
2,458,942
+38,268
| +2% | +$2.89M | 0.09% | 195 |
|
|
2022
Q3 | $172M | Sell |
2,420,674
-94,810
| -4% | -$6.88M | 0.1% | 186 |
|
|
2022
Q2 | $194M | Buy |
2,515,484
+45,388
| +2% | +$3.46M | 0.11% | 171 |
|
|
2022
Q1 | $180M | Buy |
2,470,096
+495,410
| +25% | +$33.3M | 0.09% | 196 |
|
|
2021
Q4 | $123M | Buy |
1,974,686
+208,884
| +12% | +$12.3M | 0.06% | 272 |
|
|
2021
Q3 | $104M | Buy |
1,765,802
+188,079
| +12% | +$12.4M | 0.06% | 281 |
|
|
2021
Q2 | $105M | Sell |
1,577,723
-40,879
| -3% | -$2.67M | 0.06% | 259 |
|
|
2021
Q1 | $102M | Buy |
1,618,602
+273,579
| +20% | +$17M | 0.07% | 238 |
|
|
2020
Q4 | $83.4M | Buy |
1,345,023
+16,438
| +1% | +$1.01M | 0.06% | 236 |
|
|
2020
Q3 | $80.1M | Buy |
1,328,585
+185,139
| +16% | +$11.1M | 0.07% | 215 |
|
|
2020
Q2 | $67.2M | Buy |
1,143,446
+134,896
| +13% | +$8.07M | 0.07% | 233 |
|
|
2020
Q1 | $56.2M | Buy |
1,008,550
+167,660
| +20% | +$10.2M | 0.07% | 222 |
|
|
2019
Q4 | $54M | Buy |
840,890
+166,059
| +25% | +$9.51M | 0.06% | 261 |
|
|
2019
Q3 | $34.2M | Sell |
674,831
-396,880
| -37% | -$18.7M | 0.04% | 339 |
|
|
2019
Q2 | $48.6M | Buy |
1,071,711
+435,314
| +68% | +$20.3M | 0.06% | 234 |
|
|
2019
Q1 | $30.4M | Sell |
636,397
-17,191
| -3% | -$856K | 0.04% | 322 |
|
|
2018
Q4 | $34M | Buy |
653,588
+617,905
| +1,732% | +$33.2M | 0.05% | 250 |
|
|
2018
Q3 | $2.21M | Sell |
35,683
-3,119
| -8% | -$185K | ﹤0.01% | 592 |
|
|
2018
Q2 | $2.15M | Sell |
38,802
-1,209
| -3% | -$65.3K | ﹤0.01% | 789 |
|
|
2018
Q1 | $2.46M | Sell |
40,011
-52,662
| -57% | -$3.39M | 0.01% | 636 |
|
|
2017
Q4 | $5.68M | Buy |
92,673
+42,184
| +84% | +$2.64M | 0.01% | 548 |
|
|
2017
Q3 | $3.21M | Sell |
50,489
-30,874
| -38% | -$1.8M | 0.01% | 730 |
|
|
2017
Q2 | $4.53M | Sell |
81,363
-333
| -0.4% | -$18.1K | 0.01% | 604 |
|
|
2017
Q1 | $4.44M | Sell |
81,696
-20,353
| -20% | -$1.12M | 0.01% | 610 |
|
|
2016
Q4 | $5.96M | Sell |
102,049
-87,045
| -46% | -$4.76M | 0.02% | 485 |
|
|
2016
Q3 | $10.2M | Sell |
189,094
-37,730
| -17% | -$2.42M | 0.04% | 344 |
|
|
2016
Q2 | $16.7M | Buy |
226,824
+81,308
| +56% | +$5.75M | 0.07% | 261 |
|
|
2016
Q1 | $9.3M | Sell |
145,516
-11,856
| -8% | -$748K | 0.04% | 376 |
|
|
2015
Q4 | $10.8M | Buy |
157,372
+6,771
| +4% | +$447K | 0.05% | 323 |
|
|
2015
Q3 | $8.92M | Sell |
150,601
-23,741
| -14% | -$1.51M | 0.04% | 348 |
|
|
2015
Q2 | $11.6M | Buy |
174,342
+11,030
| +7% | +$727K | 0.06% | 320 |
|
|
2015
Q1 | $10.5M | Buy |
163,312
+152,839
| +1,459% | +$9.57M | 0.05% | 339 |
|
|
2014
Q4 | $618K | Sell |
10,473
-6,008
| -36% | -$339K | 0.01% | 663 |
|
|
2014
Q3 | $843K | Buy |
16,481
+1,276
| +8% | +$63.7K | 0.01% | 625 |
|
|
2014
Q2 | $738K | Sell |
15,205
-1,023
| -6% | -$50.4K | 0.01% | 653 |
|
|
2014
Q1 | $843K | Buy |
16,228
+698
| +4% | +$37.1K | 0.01% | 521 |
|
|
2013
Q4 | $825K | Buy |
15,530
+442
| +3% | +$22.5K | 0.01% | 496 |
|
|
2013
Q3 | $698K | Sell |
15,088
-4,998
| -25% | -$219K | 0.01% | 526 |
|
|
2013
Q2 | $898K | Buy |
+20,086
| New | +$872K | 0.01% | 437 |
|
Other funds holding BMY
VCM
VPM
Envestnet Asset Management's BMY Position: Q1 2026 in Review
Envestnet Asset Management increased its Bristol-Myers Squibb (BMY) stake by 19% in Q1 2026, buying an estimated $17M and bringing the position to 1,825,394 shares worth $111M. The position accounts for 0.03% of the portfolio, ranked #498.
Envestnet Asset Management first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $200M in Q4 2024. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Envestnet Asset Management held 1,825,394 shares of Bristol-Myers Squibb worth $111M as of Q1 2026.
- Envestnet Asset Management bought 291,858 Bristol-Myers Squibb shares in Q1 2026, an estimated $17M.
- Bristol-Myers Squibb made up 0.03% of Envestnet Asset Management's portfolio in Q1 2026, its #498 holding.
- Envestnet Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Envestnet Asset Management's Bristol-Myers Squibb position peaked at $200M in Q4 2024.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Envestnet Asset Management's 13F filing for Q1 2026, filed 4 May 2026.